Bio-Rad Laboratories (BIO) Competitors $358.19 +27.61 (+8.35%) (As of 10/31/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BIO vs. MTD, ILMN, WAT, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Mettler-Toledo International Illumina Waters Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, media sentiment, risk, valuation, earnings and dividends. Is BIO or MTD more profitable? Mettler-Toledo International has a net margin of 20.95% compared to Bio-Rad Laboratories' net margin of -51.73%. Bio-Rad Laboratories' return on equity of 3.77% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories-51.73% 3.77% 2.68% Mettler-Toledo International 20.95%-575.61%24.78% Do insiders and institutionals hold more shares of BIO or MTD? 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 17.1% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 1.9% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, BIO or MTD? Bio-Rad Laboratories has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Does the MarketBeat Community prefer BIO or MTD? Mettler-Toledo International received 1 more outperform votes than Bio-Rad Laboratories when rated by MarketBeat users. However, 64.61% of users gave Bio-Rad Laboratories an outperform vote while only 56.97% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformBio-Rad LaboratoriesOutperform Votes36764.61% Underperform Votes20135.39% Mettler-Toledo InternationalOutperform Votes36856.97% Underperform Votes27843.03% Do analysts prefer BIO or MTD? Bio-Rad Laboratories currently has a consensus price target of $368.20, indicating a potential upside of 3.67%. Mettler-Toledo International has a consensus price target of $1,363.75, indicating a potential upside of 5.41%. Given Mettler-Toledo International's higher probable upside, analysts clearly believe Mettler-Toledo International is more favorable than Bio-Rad Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Mettler-Toledo International 2 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.88 Which has better earnings and valuation, BIO or MTD? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.56B3.86-$637.32M-$47.03-7.55Mettler-Toledo International$3.75B7.34$788.78M$36.3435.71 Does the media prefer BIO or MTD? In the previous week, Bio-Rad Laboratories and Bio-Rad Laboratories both had 9 articles in the media. Mettler-Toledo International's average media sentiment score of 1.17 beat Bio-Rad Laboratories' score of 0.75 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMettler-Toledo International beats Bio-Rad Laboratories on 12 of the 17 factors compared between the two stocks. Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$9.89B$5.37B$5.36B$19.21BDividend YieldN/A0.44%5.21%3.52%P/E Ratio-7.5525.49140.7931.53Price / Sales3.864.301,450.4316.82Price / Cash27.9741.2038.8820.46Price / Book1.162.484.725.39Net Income-$637.32M-$8.36M$115.38M$984.71M7 Day Performance8.29%3.90%-0.69%-0.33%1 Month Performance5.97%-3.54%3.71%-0.77%1 Year Performance28.92%-5.90%38.84%29.53% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.0775 of 5 stars$358.19+8.4%$368.20+2.8%+22.7%$9.98B$2.56B-7.628,030Earnings ReportAnalyst ForecastNews CoverageGap UpMTDMettler-Toledo International3.9514 of 5 stars$1,293.38-2.0%$1,363.75+5.4%+35.3%$27.62B$3.75B35.5916,000Upcoming EarningsPositive NewsILMNIllumina4.1469 of 5 stars$141.39-1.1%$154.33+9.2%+36.9%$22.52B$4.43B-7.389,300Upcoming EarningsWATWaters3.7388 of 5 stars$327.30-1.8%$342.58+4.7%+38.0%$19.43B$2.96B32.607,900Upcoming EarningsTECHBio-Techne4.5022 of 5 stars$68.37-1.4%$80.60+17.9%+34.2%$10.77B$1.16B65.743,100Dividend AnnouncementAnalyst ForecastNews CoverageCRLCharles River Laboratories International4.5626 of 5 stars$182.67-2.1%$209.00+14.4%+10.2%$9.41B$4.08B21.8821,800Upcoming EarningsShort Interest ↑Analyst RevisionNews CoverageBRKRBruker4.9045 of 5 stars$58.39-2.2%$80.82+38.4%+6.6%$8.49B$3.12B24.239,707Upcoming EarningsPACBPacific Biosciences of California2.8452 of 5 stars$1.72-1.7%$4.50+161.6%-69.6%$490.55M$200.52M-1.15730Upcoming EarningsHBIOHarvard Bioscience1.2581 of 5 stars$2.34-0.8%N/A-42.6%$101.63M$101.13M-9.36490Upcoming EarningsShort Interest ↑TMOThermo Fisher Scientific4.9587 of 5 stars$557.38-3.3%$655.50+17.6%+26.7%$212.92B$42.86B34.58122,000Insider SellingAAgilent Technologies4.8225 of 5 stars$130.72-1.7%$144.36+10.4%+30.0%$38.14B$6.50B27.1218,100 Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Illumina Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BIO) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
